Lu Zhang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Multiple Myeloma

Diffusion Weighted

Ejection Fraction

Top Venues

Annals of hematology

Turkish journal of haematology : official journal of Turkish Society of Haematology

British journal of haematology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Yu-Han Gao, Ming-Hui Duan, Jian Li, Lu Zhang
Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (1) (2024)
Yu-Han Gao, Ming-Hui Duan, Jian Li, Lu Zhang
Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (1) (2024)
Yan-Ting Liu, Yu-Han Gao, Hao Zhao, Miao-Yan Zhang, Ming-Hui Duan, Jian Li, Lu Zhang
Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study. Annals of hematology (2024)
Yu-Han Gao, Ming-Hui Duan, Jian Li, Lu Zhang
Successful treatment of relapsed idiopathic multicentric Castleman disease-idiopathic plasmacytic lymphadenopathy with orelabrutinib monotherapy: A case report. British journal of haematology (2024)
Lu Zhang, Yu-Han Gao, Si-Yuan Li, Hao Zhao, Miao-Yan Zhang, Yan-Ying Yu, Yan-Ting Liu, Jian Li
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease. International journal of hematology (2024)
Yu-Han Gao, Yan-Ting Liu, Miao-Yan Zhang, Si-Yuan Li, David C Fajgenbaum, Lu Zhang, Jian Li
Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival. British journal of haematology 204 (5) (2024)
Yu-Han Gao, Yan-Ting Liu, Miao-Yan Zhang, Si-Yuan Li, David C Fajgenbaum, Lu Zhang, Jian Li
Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival. British journal of haematology 204 (5) (2024)
Lu Zhang, Yu-Han Gao, Si-Yuan Li, Hao Zhao, Miao-Yan Zhang, Yan-Ying Yu, Yan-Ting Liu, Jian Li
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease. International journal of hematology 119 (6) (2024)
Si-Yuan Li, Kaini Shen, Lu Zhang
Obinutuzumab for the Treatment of Cold Agglutinin Disease: A Case Report Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (3) (2024)
Lu Zhang, Qin-Hua Liu, Hui Zhou, Hui-Lai Zhang, Yu-Jun Dong, Xiao-Bo Wang, Lu-Qun Wang, Li-Ping Su, Xiao-Jing Yan, Yan Li, Ming-Zhi Zhang, Kai-Yang Ding, Hui-Han Wang, Hong-Ling Peng, Li-Ye Zhong, Lin Yang, Lin-Tao Bi, Da Gao, Guang-Xun Gao, Liang Huang, Chun-Yan Sun, Jia Song, Wenbin Qian, Wen-Rong Huang, Zhen-Ling Li, Yao Liu, Jian Li
Asymptomatic multicentric Castleman disease: A potential early stage of idiopathic MCD. Blood advances (2024)
Yu-Han Gao, Yan-Ting Liu, Miao-Yan Zhang, Si-Yuan Li, David C Fajgenbaum, Lu Zhang, Jian Li
Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival. British journal of haematology (2024)
Yu-Han Gao, Ming-Hui Duan, Jian Li, Lu Zhang
Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (1) (2024)
Yu-Han Gao, Yan-Ting Liu, Miao-Yan Zhang, Si-Yuan Li, David C Fajgenbaum, Lu Zhang, Jian Li
Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival. British journal of haematology (2024)
Miao-Yan Zhang, Jian Li, Yi-Ning Wang, Zhuang Tian, Lu Zhang
Unicentric Castleman's disease presenting as amyloid A cardiac amyloidosis: a case report. Annals of hematology (2023)
Xiao-Hang Liu, Lu Zhang, Jian Li, Bo-Ju Pan
Rare forms of idiopathic multicentric Castleman disease presenting with intrahepatic cholestatic jaundice successfully treated with the bortezomib-based regimen: two case reports. Annals of hematology 102 (4) (2023)
Xiao-Hang Liu, Lu Zhang, Jian Li, Bo-Ju Pan
Rare forms of idiopathic multicentric Castleman disease presenting with intrahepatic cholestatic jaundice successfully treated with the bortezomib-based regimen: two case reports. Annals of hematology 102 (4) (2023)
Xiao-Hang Liu, Lu Zhang, Jian Li, Bo-Ju Pan
Rare forms of idiopathic multicentric Castleman disease presenting with intrahepatic cholestatic jaundice successfully treated with the bortezomib-based regimen: two case reports. Annals of hematology 102 (4) (2023)
Xiao-Hang Liu, Lu Zhang, Jian Li, Bo-Ju Pan
Rare forms of idiopathic multicentric Castleman disease presenting with intrahepatic cholestatic jaundice successfully treated with the bortezomib-based regimen: two case reports. Annals of hematology 102 (4) (2023)
Yu-Han Gao, Qin Wang, Lu Zhang, Shuo Li, Dong Liu, Shitian Wang, Jinxia Zhu, Haibo Zhang, Sheng Xie, Shuang Xia, Wenyang Huang, Hua-Dan Xue, Jian Li
Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging. Journal of magnetic resonance imaging : JMRI (2023)
Xiao-Hang Liu, Lu Zhang, Jian Li, Bo-Ju Pan
Rare forms of idiopathic multicentric Castleman disease presenting with intrahepatic cholestatic jaundice successfully treated with the bortezomib-based regimen: two case reports. Annals of hematology (2023)
Ya-Juan Gao, Kai-Ni Shen, Hui-Lei Miao, Zhuang Tian, Jun Feng, Lu Zhang, Xin-Xin Cao, Dao-Bin Zhou, Jian Li
A retrospective study of ultrahigh-risk (Mayo 2004 stage IIIb) AL amyloidosis and identification of predictors related to extremely early death. Leukemia & lymphoma 63 (7) (2022)
Yujie Shi, Jian Li, Lu Zhang
Daratumumab for the treatment of refractory idiopathic multicentric Castleman disease: a case report. Annals of hematology 101 (11) (2022)
Lu Zhang, Miao-Yan Zhang, Xin-Xin Cao, Dao-Bin Zhou, David C Fajgenbaum, Yu-Jun Dong, Jian Li
A prospective, multicenter study of bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory iMCD. Leukemia & lymphoma 63 (3) (2022)
Wanlu Ma, Boju Pan, Lu Zhang
Gastric Cancer or Plasmacytoma in a Seemingly Well-Controlled Multiple Myeloma Patient? Turkish journal of haematology : official journal of Turkish Society of Haematology 38 (2) (2021)
Wanlu Ma, Jiawei Zhao, Lu Zhang
A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia Turkish journal of haematology : official journal of Turkish Society of Haematology 38 (1) (2020)